Oxytocin Quick Start
Oxytocin is a nonapeptide produced in the hypothalamus and released from the posterior pituitary. Beyond its established peripheral roles it is one of the most heavily studied peptides in social and behavioural neuroscience, where essentially all research uses the intranasal route and reports doses in international units rather than micrograms. That IU convention is the single most important thing to get right when reading the literature against a milligram vial.
This guide is an educational research reference. It does not diagnose, treat, or prescribe, and is not medical advice. Consult a licensed clinician before considering any compound.
Oxytocin Dosing Protocol
Published social-cognition research is dominated by a single intranasal reference dose — 24 IU, with a studied range of roughly 10–40 IU. Because the vial is labelled in milligrams, the conversion below is the bridge between the literature and the material. These are research-planning references, not personal dosing recommendations.
Injection — Subcutaneous
| Band | Per dose (IU) | Equivalent mass | Frequency |
|---|---|---|---|
| Low | 10 IU | ~17 mcg | Per session |
| Standard | 24 IU | ~40 mcg | Per session |
| High | 40 IU | ~67 mcg | Per session |
Oxytocin Reconstitution Guide
Oxytocin is supplied as a lyophilized powder, so the vehicle and device are the researcher's choice. The practical problem is that the studied route is intranasal at microgram doses, which means diluting far more than a subcutaneous protocol would.
Injection
| BAC | Conc. | 24 IU (~40 mcg) |
|---|---|---|
| 2 mL | 2,500 mcg/mL | 0.016 mL · 1.6 u |
| 5 mL | 1,000 mcg/mL | 0.04 mL · 4 u |
Units are U-100 insulin-syringe units. Note how small these draws are — a 1.6-unit draw is below what a U-100 syringe reads reliably, which is part of why the literature uses metered nasal delivery instead.
For intranasal delivery
Per-spray dose = concentration × actuation volume. To land near 24 IU in a single 0.1 mL actuation you need roughly 400 mcg/mL — about 5 mg into 12.5 mL, which exceeds a standard vial, so a partial batch is prepared instead. Measure your sprayer rather than assuming 0.1 mL.
Reconstitution steps
- Inspect the vial. Confirm the label, expected milligram amount, and that the powder looks dry and intact.
- Wipe the stoppers. Use an alcohol swab on both the bacteriostatic water and peptide vial stoppers.
- Draw the chosen volume. 2 mL for injection, or a larger volume for intranasal into the vial — this is the number that sets every concentration figure above.
- Inject down the wall. Release the water slowly down the inside wall, not directly onto the powder.
- Swirl, do not shake. Roll gently until dissolved. Shaking foams and can damage the peptide.
- Verify clarity. Solution should be clear and colorless. Discard if cloudy or particulate.
- Label and refrigerate. Note the date and volume added on the vial, then store at 2–8 °C. Do not freeze the reconstituted solution.
See the bacteriostatic water guide for diluent handling, or the reconstitution calculator to work any other volume.
How Oxytocin Works
Oxytocin acts at the oxytocin receptor, a G-protein-coupled receptor expressed peripherally in uterine and mammary tissue and centrally in regions including the amygdala, hypothalamus and striatum. Central effects on social salience, trust and threat processing are the focus of the behavioural literature. Intranasal delivery is used because oxytocin crosses the blood-brain barrier poorly, though how much actually reaches the brain by that route remains genuinely contested.
Oxytocin receptor
GPCR with both peripheral (uterine, mammary) and central expression.
Amygdala modulation
Reduced amygdala reactivity to threat cues is among the more replicated imaging findings.
Social salience
The dominant framing is modulation of attention to social cues rather than a simple prosocial effect.
Open question
How much intranasal oxytocin reaches the central nervous system is still actively disputed.
Who Should Avoid Oxytocin
Oxytocin has potent peripheral activity on uterine smooth muscle, which makes one exclusion far more serious than the rest.
Pregnancy
Oxytocin induces uterine contraction — this is its established clinical pharmacology and an absolute exclusion outside supervised obstetric care.
Cardiovascular conditions
Rapid or high-dose administration has recognised cardiovascular effects; relevant to any non-clinical use.
Hyponatraemia risk
Oxytocin has antidiuretic activity; water intoxication is documented with high-dose clinical use.
Psychiatric conditions
Effects on social and emotional processing are context-dependent and not uniformly positive.
Oxytocin Side Effects & Safety
Uterine activity
The most serious consideration. Oxytocin is a uterotonic and this is not a theoretical property.
Antidiuretic effect
Structural similarity to vasopressin gives it antidiuretic activity; hyponatraemia is documented at clinical doses.
Context-dependent behavioural effects
Research reports effects that vary with individual and social context, including negative ones — not a uniformly prosocial compound.
Nasal irritation
The most common route-specific complaint in intranasal studies.
Oxytocin Evidence Context
Large behavioural literature
Hundreds of intranasal studies in social cognition, most using the 24 IU convention.
Replication concerns
The field has been the subject of prominent replication and publication-bias critiques.
Established peripheral pharmacology
Its uterotonic and lactation roles are clinically established and not in question.
Open question
Central bioavailability by the intranasal route — the assumption the entire behavioural literature rests on.
Storage & Handling
| State | Storage | Notes |
|---|---|---|
| Lyophilized (powder) | −20 °C, protected from light | More stable than reconstituted solution. |
| Reconstituted (liquid) | 2–8 °C ~28 days | Freeze for longer storage per the listing. |
| Appearance | Clear, colorless | Discard cloudy or particulate solutions. |
Frequently Asked Questions
What is oxytocin?
A nine-amino-acid cyclic neuropeptide produced in the hypothalamus, with established peripheral roles and a very large behavioural-neuroscience literature using intranasal delivery.
Why is the literature in IU rather than mg?
Oxytocin has long been standardised biologically rather than by mass. Roughly 1 IU is 1.68 mcg, so the standard 24 IU research dose is about 40 mcg.
How many IU are in a 5 mg vial?
Approximately 2,975 IU — on the order of 124 doses at the 24 IU reference.
Can it be injected instead?
The behavioural literature is essentially all intranasal, and the equivalent injected volumes are too small to measure reliably on a U-100 syringe. Injectable oxytocin exists clinically but for different indications entirely.
What is the most serious safety issue?
Uterine contraction. Oxytocin is a clinically established uterotonic, which makes pregnancy an absolute exclusion outside supervised obstetric care.
Is this page medical advice?
No. It is an educational research reference and does not diagnose, treat, or prescribe. Consult a licensed clinician before considering any compound.
Oxytocin Formats & Sourcing
Oxytocin is supplied as a lyophilized powder in a single 5 mg vial. There is no pre-mixed nasal spray format — intranasal work requires loading the reconstituted solution into a metered sprayer. Batch-specific Certificates of Analysis are issued per lot.
| Format | Supplied as |
|---|---|
| Vial | 5 mg lyophilized powder |
Strengths are listed as sold; confirm against the product page and the batch COA before calculating anything.
Reference material for this protocol, with batch COA:
View Oxytocin on Spyro Peptides →References
- Kosfeld M, et al. Oxytocin increases trust in humans. Nature (2005).
- Guastella AJ, et al. Recommendations for the standardisation of oxytocin nasal administration. Psychoneuroendocrinology (2013).
- Leng G, Ludwig M. Intranasal oxytocin: myths and delusions. Biol Psychiatry (2016).
- Quintana DS, et al. Advances in the field of intranasal oxytocin research. Transl Psychiatry (2021).
- Conversion basis: oxytocin USP potency, approximately 600 IU per mg of peptide.